GENETIC PROFILING AND BANKING SYSTEM AND METHOD

• US 20120271656A1
• Filed: 06/29/2012
• Published: 10/25/2012
• Est. Priority Date: 10/22/1999
• Status: Active Grant

• Current Assignee: Cerner Innovation, Inc. (Oracle Corporation)
• Original Assignee: Cerner Innovation, Inc. (Oracle Corporation)
• Inventors: HOLDEN, ARTHUR L.
• Granted Patent: US 8,682,695 B2
• Time in Patent Office: Days
• US Class Current: 705/3
• CPC Class Codes: G06Q 20/108 Remote banking, e.g. home banking
• CPC Class Codes: G06Q 20/382 insuring higher security of transaction
• CPC Class Codes: G16B 50/00 ICT programming tools or database systems specially adapted for bioinformatics
• CPC Class Codes: G16B 50/30 Data warehousing; Computing architectures
• CPC Class Codes: G16B 50/40 Encryption of genetic data
• CPC Class Codes: G16H 10/60 for patient-specific data, e.g. for electronic patient records

Abstract

A method is provided for determining whether a third party is authorized to access information representative of genetic data. This information representative of genetic data is associated with a physical sample and is provided in an accessible format. A set or access rights is received that define which third parties can access the information and how the information can be used. A third party requests to access the information for the purposes of performing a test. The request is compared to the access rights. If the third party is authorized, the test is performed on the information. If, however, the third party is not authorized, access is denied.

Claims

1. A method for determining authorization for a third party, the method comprising:

providing information representative of genetic data associated with a physical sample in an accessible format;

receiving a set of access rights defining conditions under which third parties can access the information;

receiving a request from a third party to access the information for a particular use;

comparing, at a computing device having a processor, the third party request with the access rights to confirm that the third party is authorized to access the information requested for the particular use;

if the third party is authorized, allowing the third party access to the information for the particular use; and

if the third party is not authorized, denying access.

2. The method of claim 1, wherein the information representative of the genetic data comprises one or more of:

(1) data representing levels of express of nucleic acids or proteins from the physical sample,

(2) a genotype of the physical sample,

(3) a molecular profile from the physical sample,

(4) data associated with a genetic marker panel, or

(5) data associated with a disease phenotype.

3. The method of claim 1, wherein the physical sample is one or more of a sample of cells, a tissue sample, a sample of blood and its derivatives, or bodily fluids.

4. The method of claim 1, wherein receiving the request from a third party to access the information for a particular use includes receiving the request to compare the genetic or molecular data against at least one marker associated with a condition.

5. The method of claim 1, wherein receiving the request from a third party to access the information for a particular use includes receiving the request to compare the genetic data against at least one allelic variant.

6. The method of claim 1, further comprising providing an indication when the request to access the data has been denied.

7. The method of claim 1, wherein the particular use includes comparing the information to other data associated with a known disease.

8. The method of claim 1, wherein the particular use includes identifying in the information at least one of a number of genetic or molecular markers associated with certain disease phenotypes.

9. A system embodied on a computing device having a processor for determining authorization for a third party, the system comprising:

a processing system configured for receiving a request from a third party to access genetic data for a particular use, wherein the genetic data is stored in a database; and

an access control system configured for determining whether the third party is authorized to access the genetic data for the particular use based on stored access rights, wherein;

if the third party is authorized to access the genetic data, allowing the third party access to the genetic data for the particular use, and

if the third party is not authorized to access the genetic data, denying access to the third party for the particular use.

10. The system of claim 9, wherein the third party request includes a request to compare the genetic or molecular data against at least one marker associated with a condition.

11. The system of claim 9, wherein the third party request includes a request to compare the genetic data against at least one allelic variant.

12. The system of claim 9, wherein the access control system is further configured for comparing the stored information to other data associated with a known disease.

13. The system of claim 9, wherein the access control system is further configured for identifying in the stored information at least one of a number of genetic or molecular markers associated with certain disease phenotypes.

14. A method embodied on a computing device having a processor and a memory for determining authorization for a third party, the method comprising:

receiving from a third party at the computing device a request to access stored genetic data of a patient for a particular use to determine the presence or absence of a gene or genetic variant or level of expression of a marker associated with a specified disease;

determining, at the computing device having the processor, whether the third party is authorized to access the genetic data for the particular use based on stored access rights;

if the third party user is authorized to access the genetic data for the particular use, allowing the third party to access the genetic data and reporting the results of the presence or absence of the gene or genetic variant or the level of expression of the marker associated with the specified disease to the third party; and

if the third party is not authorized to access the genetic data for the particular use, denying access to the third party for the particular use.

15. The method of claim 14, further comprising processing a physical sample to generate genetic information representative of the genetic data associated with the physical sample.

16. The method of claim 15, wherein the physical sample is one or more of a sample of cells, a tissue sample, a sample of blood and its derivatives, or bodily fluids.

17. The method of claim 14, wherein the request is received over the Internet.

18. The method of claim 14, wherein the particular use includes determining whether a specific genetic variant is present.

19. The method of claim 14, wherein the particular use includes determining the level of express of a specific gene.

20. The method of claim 14, wherein the stored access rights indicate which third parties have access to the genetic data and uses for the access to the genetic data.